US Bancorp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $80.6M | Sell |
1,329,743
-8,854
| -0.7% | -$516K | 0.1% | 150 |
|
|
2025
Q4 | $72.2M | Sell |
1,338,597
-119,454
| -8% | -$5.75M | 0.08% | 155 |
|
|
2025
Q3 | $65.8M | Sell |
1,458,051
-107,836
| -7% | -$5.04M | 0.08% | 172 |
|
|
2025
Q2 | $72.5M | Sell |
1,565,887
-82,039
| -5% | -$4.03M | 0.09% | 155 |
|
|
2025
Q1 | $101M | Sell |
1,647,926
-45,158
| -3% | -$2.63M | 0.13% | 125 |
|
|
2024
Q4 | $95.8M | Sell |
1,693,084
-246,542
| -13% | -$13.8M | 0.13% | 131 |
|
|
2024
Q3 | $100M | Sell |
1,939,626
-130,713
| -6% | -$6.13M | 0.13% | 129 |
|
|
2024
Q2 | $86M | Sell |
2,070,339
-297,321
| -13% | -$13.3M | 0.12% | 132 |
|
|
2024
Q1 | $128M | Sell |
2,367,660
-120,242
| -5% | -$6.13M | 0.18% | 104 |
|
|
2023
Q4 | $128M | Sell |
2,487,902
-191,438
| -7% | -$10M | 0.19% | 100 |
|
|
2023
Q3 | $155M | Sell |
2,679,340
-73,644
| -3% | -$4.51M | 0.25% | 76 |
|
|
2023
Q2 | $176M | Sell |
2,752,984
-78,158
| -3% | -$5.24M | 0.28% | 71 |
|
|
2023
Q1 | $196M | Sell |
2,831,142
-86,342
| -3% | -$6.09M | 0.33% | 67 |
|
|
2022
Q4 | $210M | Buy |
2,917,484
+611,914
| +27% | +$46.1M | 0.37% | 63 |
|
|
2022
Q3 | $164M | Sell |
2,305,570
-83,581
| -3% | -$6.06M | 0.34% | 66 |
|
|
2022
Q2 | $184M | Sell |
2,389,151
-49,779
| -2% | -$3.79M | 0.36% | 63 |
|
|
2022
Q1 | $178M | Sell |
2,438,930
-46,333
| -2% | -$3.11M | 0.3% | 74 |
|
|
2021
Q4 | $155M | Sell |
2,485,263
-50,996
| -2% | -$2.99M | 0.24% | 90 |
|
|
2021
Q3 | $150M | Sell |
2,536,259
-33,418
| -1% | -$2.2M | 0.28% | 80 |
|
|
2021
Q2 | $172M | Sell |
2,569,677
-5,411
| -0.2% | -$353K | 0.32% | 71 |
|
|
2021
Q1 | $163M | Sell |
2,575,088
-16,832
| -0.6% | -$1.05M | 0.33% | 71 |
|
|
2020
Q4 | $161M | Sell |
2,591,920
-37,466
| -1% | -$2.3M | 0.35% | 68 |
|
|
2020
Q3 | $159M | Sell |
2,629,386
-29,898
| -1% | -$1.8M | 0.39% | 62 |
|
|
2020
Q2 | $156M | Sell |
2,659,284
-25,891
| -1% | -$1.55M | 0.41% | 59 |
|
|
2020
Q1 | $150M | Sell |
2,685,175
-84,954
| -3% | -$5.19M | 0.47% | 51 |
|
|
2019
Q4 | $178M | Buy |
2,770,129
+594,575
| +27% | +$34.1M | 0.45% | 56 |
|
|
2019
Q3 | $110M | Sell |
2,175,554
-1,208
| -0.1% | -$56.8K | 0.3% | 81 |
|
|
2019
Q2 | $98.7M | Buy |
2,176,762
+16,620
| +0.8% | +$774K | 0.28% | 83 |
|
|
2019
Q1 | $103M | Sell |
2,160,142
-800
| -0% | -$39.9K | 0.3% | 77 |
|
|
2018
Q4 | $112M | Sell |
2,160,942
-31,368
| -1% | -$1.69M | 0.36% | 68 |
|
|
2018
Q3 | $136M | Sell |
2,192,310
-30,125
| -1% | -$1.79M | 0.39% | 67 |
|
|
2018
Q2 | $123M | Sell |
2,222,435
-38,580
| -2% | -$2.08M | 0.38% | 68 |
|
|
2018
Q1 | $143M | Buy |
2,261,015
+34,576
| +2% | +$2.22M | 0.44% | 51 |
|
|
2017
Q4 | $136M | Sell |
2,226,439
-20,446
| -0.9% | -$1.28M | 0.42% | 58 |
|
|
2017
Q3 | $143M | Sell |
2,246,885
-29,282
| -1% | -$1.71M | 0.46% | 52 |
|
|
2017
Q2 | $127M | Sell |
2,276,167
-72,459
| -3% | -$3.94M | 0.42% | 62 |
|
|
2017
Q1 | $128M | Sell |
2,348,626
-48,765
| -2% | -$2.67M | 0.44% | 58 |
|
|
2016
Q4 | $140M | Buy |
2,397,391
+5,296
| +0.2% | +$290K | 0.5% | 41 |
|
|
2016
Q3 | $129M | Sell |
2,392,095
-92,761
| -4% | -$5.96M | 0.48% | 51 |
|
|
2016
Q2 | $183M | Sell |
2,484,856
-56,435
| -2% | -$3.99M | 0.7% | 30 |
|
|
2016
Q1 | $162M | Sell |
2,541,291
-13,338
| -0.5% | -$841K | 0.64% | 32 |
|
|
2015
Q4 | $176M | Sell |
2,554,629
-63,990
| -2% | -$4.23M | 0.71% | 26 |
|
|
2015
Q3 | $155M | Sell |
2,618,619
-98,195
| -4% | -$6.23M | 0.65% | 30 |
|
|
2015
Q2 | $181M | Sell |
2,716,814
-27,822
| -1% | -$1.83M | 0.7% | 29 |
|
|
2015
Q1 | $177M | Sell |
2,744,636
-45,691
| -2% | -$2.86M | 0.68% | 26 |
|
|
2014
Q4 | $165M | Sell |
2,790,327
-19,735
| -0.7% | -$1.11M | 0.64% | 34 |
|
|
2014
Q3 | $144M | Sell |
2,810,062
-30,769
| -1% | -$1.54M | 0.58% | 39 |
|
|
2014
Q2 | $138M | Sell |
2,840,831
-91,218
| -3% | -$4.5M | 0.55% | 41 |
|
|
2014
Q1 | $152M | Buy |
2,932,049
+14,203
| +0.5% | +$756K | 0.62% | 37 |
|
|
2013
Q4 | $155M | Sell |
2,917,846
-86,860
| -3% | -$4.42M | 0.63% | 36 |
|
|
2013
Q3 | $139M | Sell |
3,004,706
-30,700
| -1% | -$1.35M | 0.61% | 38 |
|
|
2013
Q2 | $136M | Buy |
+3,035,406
| New | +$132M | 0.62% | 38 |
|
Other funds holding BMY
VCM
VPM
US Bancorp's BMY Position: Q1 2026 in Review
US Bancorp reduced its Bristol-Myers Squibb (BMY) stake by 0.66% in Q1 2026, selling an estimated $516K and leaving 1,329,743 shares worth $80.6M. The position accounts for 0.1% of the portfolio, ranked #150.
US Bancorp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $210M in Q4 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- US Bancorp held 1,329,743 shares of Bristol-Myers Squibb worth $80.6M as of Q1 2026.
- US Bancorp sold 8,854 Bristol-Myers Squibb shares in Q1 2026, an estimated $516K.
- Bristol-Myers Squibb made up 0.1% of US Bancorp's portfolio in Q1 2026, its #150 holding.
- US Bancorp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- US Bancorp's Bristol-Myers Squibb position peaked at $210M in Q4 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.